Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Evaluation Of The Treatment Results Of Laryngeal Carcinoma: Our Experience Over 10 Years, Erkan Karataş, Eli̇f Baysal, Cengi̇z Durucu, Teki̇n Bağlam, Yildirim Ahmet Bayazit, Muzaffer Kanlikama
Evaluation Of The Treatment Results Of Laryngeal Carcinoma: Our Experience Over 10 Years, Erkan Karataş, Eli̇f Baysal, Cengi̇z Durucu, Teki̇n Bağlam, Yildirim Ahmet Bayazit, Muzaffer Kanlikama
Turkish Journal of Medical Sciences
To retrospectively analyze the treatment results for laryngeal carcinoma and to find the impact of the clinical parameters on the survival of the patients. Materials and methods: The medical records of 150 consecutive patients, operated on for laryngeal squamous cell carcinoma between 1991 and 2009, were reviewed. Tumor localization, TNM stages, treatment modalities, radiotherapy, second primary tumors, and tumor recurrence were recorded, and the survival data were obtained. Results: Neck metastasis was rare (3.6%) in T1 and T2 glottic tumors, while there was a significant increase in the rate of N+ neck (35%) in T3 and T4 glottic tumors (P …
Hematologic, Cytogenetic, And Molecular Responses To Imatinib Therapy For Chronic Myeloid Leukemia: A Single-Center Experience In Turkey, Yusuf Bi̇len, Fuat Erdem
Hematologic, Cytogenetic, And Molecular Responses To Imatinib Therapy For Chronic Myeloid Leukemia: A Single-Center Experience In Turkey, Yusuf Bi̇len, Fuat Erdem
Turkish Journal of Medical Sciences
To validate patient responses to imatinib mesylate, which induces hematologic and cytogenetic remission and, consequently, modifies the progression of chronic myeloid leukemia (CML). Materials and methods: Between January 2006 and July 2009, 31 patients with chronic-phase CML were treated with imatinib therapy in the hematology unit of Atatürk University Medical Faculty Training Hospital. Imatinib treatment was begun at the standard dose of 400 mg/day, as either first-line or second-line therapy. Results: At the end of the second month of treatment, all of the patients had achieved complete hematologic response. After 12 months, the rate of complete cytogenetic response was 71%, …
The Evaluation Of The Results Of Adjuvant Chemoradiotherapy In Patients With Gastric Cancer: Results From A Single Center In Eastern Anatolia, Mehmet Bi̇li̇ci̇, Sali̇m Başol Teki̇n, Mustafa Kandaz, Keri̇m Çayir, Mustafa Vecdi̇ Erteki̇n, Hi̇lal Kiziltunç Özmen
The Evaluation Of The Results Of Adjuvant Chemoradiotherapy In Patients With Gastric Cancer: Results From A Single Center In Eastern Anatolia, Mehmet Bi̇li̇ci̇, Sali̇m Başol Teki̇n, Mustafa Kandaz, Keri̇m Çayir, Mustafa Vecdi̇ Erteki̇n, Hi̇lal Kiziltunç Özmen
Turkish Journal of Medical Sciences
To evaluate the results of postoperative chemoradiotherapy in patients with gastric cancer. Gastric cancer is an important public health problem in Turkey, especially in the eastern Anatolia region. Surgery is the primary modality for managing early-stage disease, but most patients who undergo a curative resection develop locoregional or distant recurrence. Therefore, the administration of adjuvant treatment in gastric cancer has great importance. Materials and methods: Operated patients with stage IB-IV (M0) gastric cancer were enrolled in this study. A total of 148 patients with gastric cancer who had completed adjuvant chemoradiotherapy were evaluated retrospectively. Total overall survival (OS), disease-free survival …
The Impact Of Nephrometry Score On Partial Nephrectomy Rates And Survival, Ali̇ Barbaros Başeski̇oğlu, Yunus Sai̇m Cavi̇t Can, Aydin Yeni̇lmez, Coşkun Kaya
The Impact Of Nephrometry Score On Partial Nephrectomy Rates And Survival, Ali̇ Barbaros Başeski̇oğlu, Yunus Sai̇m Cavi̇t Can, Aydin Yeni̇lmez, Coşkun Kaya
Turkish Journal of Medical Sciences
Aim: To evaluate the utility of the nephrometry score (NS) and its effects on survival using our experiences with renal tumor data. Materials and methods: Data from 220 patients who underwent renal tumor surgery between 2002 and 2008 were analyzed retrospectively. The exclusion criteria were lack of preoperative tomography films or pathological data and loss of patients for follow-up. Preoperative computed tomography of the patients was evaluated according to the R.E.N.A.L. NS system at www.nephrometry.com, and low, moderate, and high complexity groups were compared. A cut-off point of 8 for the NS was determined and patients were grouped. Kaplan-Meier and …